Contact us: +91 9550333722 040 - 40102781

Chemicalbook Indiar

Structured search

India

Choose your country
Different countries will display different contents

China United Kingdom South Korea Germany Japan India

Try our best to find the right business for you.

My chemicalbook

Welcome back!

Home Product name list(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

CAS NO.：872980-38-6
Empirical Formula: C28H31ClO10
Molecular Weight: 562.99

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate Structural

What is (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate?

The Uses of (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

Empagliflozin Methoxy impurityis an impurity of Empagliflozin. Empagliflozin is a novel, potent and selective SGLT-2 inhibitor. It improves glycaemic control syndrome in diabetic rats.

Properties of (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

Boiling point:	617.0±55.0 °C(Predicted)
Density	1.31±0.1 g/cm3(Predicted)

Safety information for (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

Computed Descriptors for (2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3- (4-methoxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

New Products

Tert-butyl bis(2-chloroethyl)carbamate (S)-3-Aminobutanenitrile hydrochloride N-Boc-D-alaninol N-BOC-D/L-ALANINOL N-octanoyl benzotriazole 4-Hydrazinobenzoic acid 3,4-Dibenzyloxybenzaldehyde 1,1’-CARBONYLDIIMIDAZOLE R-2-BENZYLOXY PROPIONIC ACID 1,1’-CARBONYLDI (1,2-4 TRIAZOLE) 4-HYDROXY BENZYL ALCOHOL 3-NITRO-2-METHYL ANILINE (2-Hydroxyphenyl)acetonitrile 4-Bromopyrazole 5-BROMO-2CYANO PYRIDINE 5,6-Dimethoxyindanone 5-broMo-2-chloro-N-cyclopentylpyriMidin-4-aMine 4-methoxy-3,5-dinitropyridine 2-(Cyanocyclohexyl)acetic acid 2-aminopropyl benzoate hydrochloride 1-(4-(aminomethyl)benzyl)urea hydrochloride tert-butyl 4- (ureidomethyl)benzylcarbamate diethyl 2-(2-((tertbutoxycarbonyl)amino) ethyl)malonate Ethyl-2-chloro((4-methoxyphenyl)hydrazono)acetate

Related products of tetrahydrofuran

Dapagliflozin Impurity 28

Dapagliflozin Impurity 28

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-chloro-3-(4- hydroxybenzyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate

Dapagliflozin Impurity G

Dapagliflozin Impurity G

Dapagliflozin Open Ring

Dapagliflozin Open Ring

Dapagliflozin Impurity 21

Dapagliflozin Impurity 21

Ortho-Isomer of Dapagliflozin

Ortho-Isomer of Dapagliflozin

(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol

(2R,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxyMethyl)tetrahydro-2H-pyran-3,4,5-triol

Dapagliflozin Impurity 1

Dapagliflozin Impurity 1

You may like

873-83-6 6-Aminouracil (or) 4-Amino-2,6- dihydroxypyrimidine, (or) 6-Amino2,4-pyrimidinediol 99%
873-83-6
View Details
55441-95-7 99%
55441-95-7
View Details
N-Vinylformamide 99%
13162-05-5
View Details
Chloro Uracil 1820-81-1 99%
1820-81-1
View Details
207557-35-5 99%
207557-35-5
View Details
2-ethyl-6-methyl-3-hydroxypyridine succinate 99%
127464-43-1
View Details
2-ETHYLPYRIDINE 100-71-0 99%
100-71-0
View Details
181228-33-1 (S)-Methyl 3-amino-2-((tert-butoxycarbonyl)amino)propanote Hydrochloride (DAP-OMe. HCl) 99%
181228-33-1
View Details

Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.